Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement
Kakkar, V.V.; Bentley, P.G.; Lawrence, D.; de Haas, H.A.; Ward, V.P.
Münchener Medizinische Wochenschrift 121(36): 1152-1154
1979
ISSN/ISBN: 0341-3098 PMID: 114786 Document Number: 146537
Document emailed within 1 workday
Related Documents
Lindblad, B. 1988: Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. a review Acta Chirurgica Scandinavica. Supplementum 543: 31-42Lüders, K.; Konold, P.; Otten, G.; Koslowski, L. 1973: Prevention of postoperative thromboembolism. Randomized, prospective study of the comparison of thromboembolism prevention using anticoagulants (Heparin-Marcumar) and dextran 60 (Macrodex) Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 44(12): 563-569
Bergqvist, D. 1990: Low molecular weight heparin--preventive supplementation against postoperative venous thromboembolism Lakartidningen 87(8): 562-564
Heit, J.A.; Berkowitz, S.D.; Bona, R.; Cabanas, V.; Corson, J.D.; Elliott, C.G.; Lyons, R. 1997: Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group Thrombosis and Haemostasis 77(1): 32-38
Chong, B.H. 1996: Prevention of postoperative venous thromboembolism Medical Journal of Australia 164(11): 646-647
Iorio, A.; Agnelli, G. 2000: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis Archives of Internal Medicine 160(15): 2327-2332
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Cser, I. 1988: Observations with subcutaneous heparin calcium used for the prevention of postoperative thromboembolism in orthopaedic surgery cases Therapia Hungarica 36(1): 16-19
von Felten, A. 1992: Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex Therapeutische Umschau. Revue Therapeutique 49(12): 837-842
Mcgarry, L.J.; Thompson, D. 2004: Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice Clinical Therapeutics 26(3): 419-430
Clarke-Pearson, D.L.; Synan, I.S.; Hinshaw, W.M.; Coleman, R.E.; Creasman, W.T. 1984: Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy Obstetrics and Gynecology 63(1): 92-98
Caprini, J.A.; Arcelus, J.; Sehgal, L.R.; Cohen, E.B.; Reyna, J.J. 2002: The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States International Angiology: a Journal of the International Union of Angiology 21(1): 78-85
Seccia, M.; Bellomini, M.G.; Goletti, O.; Tortora, A.; Buccianti, P.; Chiarugi, M.; Bertolucci, A.; Martino, M.C.; Macaluso, C.; Cavina, E. 1992: The prevention of postoperative deep venous thrombosis with heparan sulfate per os. A controlled clinical study vs. heparin calcium Minerva Chirurgica 47(1-2): 45-48
Oberst, M.; Vierling, P.; Thielemann, F. 1998: Heparin-associated thrombocytopenia (HAT) type II. An underestimated complication in prevention of thromboembolism with heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 69(2): 198-203
Haas, S. 1995: Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis Deutsche Medizinische Wochenschrift 120(14): 503
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Meyer, G. 2015: Is there still a place for unfractionated heparin in venous thromboembolism? La Revue du Praticien 65(2): 199
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Jacobsen, A.F.; Qvigstad, E.; Sandset, P.M. 2000: Treatment of venous thromboembolism in pregnancy with low molecular weight heparin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2448-2449
Di Carlo, V.; Agnelli, G.; Prandoni, P.; Coccheri, S.; Gensini, G.F.; Gianese, F.; Mannucci, P.M. 1999: Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group Thrombosis and Haemostasis 82(1): 30-34